Showing posts with label Alzheimers. Show all posts
Showing posts with label Alzheimers. Show all posts

Tuesday, 20 August 2013

Copper build up in brain 'could explain Alzheimer's dementia'

Featured Article
Academic Journal
Main Category: Alzheimer's / Dementia
Also Included In: Neurology / Neuroscience;  Water - Air Quality / Agriculture
Article Date: 20 Aug 2013 - 3:00 PDT Current ratings for:
Copper build up in brain 'could explain Alzheimer's dementia'
not yet ratednot yet rated

New research suggests copper that enters the body at levels encountered in the average modern diet may be leading, eventually, to Alzheimer's disease - by reducing the body's ability to clear away toxic proteins in the brain, and also by encouraging the clumping of those proteins.

Copper is an essential trace element in the diet. With iron, it helps make red blood cells, and it is also essential for the health of the immune system, blood vessels, nerves, and bones.

Copper enters the body via many sources, including drinking water carried in copper pipes, and from foods such as shellfish, nuts, red meat and many fruits and vegetables, and also via food supplements.

But now a study that used cells from both mice and humans, led by Rashid Deane, a research professor in the University of Rochester Medical Center (URMC) in the US, shows that copper can also build up in the brain and disrupt the body's ability to clear away amyloid beta proteins before they form the plaques that are the hallmark Alzheimer's disease.

Prof Deane says:

"It is clear that, over time, copper's cumulative effect is to impair the systems by which amyloid beta is removed from the brain."

He and his co-authors, all with URMC, write about their findings in Monday's online issue of the Proceedings of the National Academy of Sciences.

Normally, the body removes amyloid beta from the brain with the help of a protein called LRP1, short for lipoprotein receptor-related protein 1. This protein, which lines blood vessels in the brain, binds with amyloid beta and escorts it out of the brain.

For their study, the team gave mice trace levels of copper for three months.

They found the metal collected in the cells walls of the fine vessels that feed blood to the brain.

The cells the copper collected in are an important part of the brain's defence mechanism, the so-called blood/brain barrier, which controls the substances that can pass in and out of brain tissue.

By collecting copper in their membranes, the cells were just doing their job.

But the researchers found that with time, through the process of oxidation, the copper build up in the cell walls started to affect the ability of LRP1 to escort amyloid beta proteins out of the brain. They saw this happen in both mouse and human brain cells.

In a further experiment, they then examined the process in live mice bred to develop Alzheimer's disease. They found the cells responsible for maintaining the blood/brain barrier could not cope: they became leaky, probably with age and repeated damage from toxins.

Had they not been leaky, the cells would have trapped the copper in their cell walls, but in the Alzheimer's mice, the blood-borne metal was able to pass unhindered through the blood/brain barrier.

As it met with brain tissue, the leaked copper stimulated brain cells to increase their production of amyloid beta.

The copper also had a direct effect on the toxic protein itself: it encouraged it to clump together and form the characteristic plaques of Alzheimer's disease.

Once amyloid beta forms these large clumps inside brain cells, the body's natural ways of eliminating it are overwhelmed and cannot cope: scientists believe this is how Alzheimer's starts and progresses.

In a final experiment, the team also found that copper led to inflammation of brain tissue, which may also speed up the breakdown of the blood/brain barrier and the subsequent build up of Alzheimer's toxins.

The levels of copper the researchers used in their experiments were trace amounts, about one-tenth of that set by standards for water quality from the US Environmental Protection Agency.

Prof Deane says:

"These are very low levels of copper, equivalent to what people would consume in a normal diet."

But neither he nor his colleagues are suggesting people change their diets or intakes of copper on the basis of these findings, which they say should be interpreted with caution.

The body needs copper, it is an essential metal. The effects shown in this study are due to exposure over a long period, and the key is getting the balance between too much and too little.

"Right now we cannot say what the right level will be, but diet may ultimately play an important role in regulating this process," Prof. Deane says.

Help with finding for the study came from The Alzheimer's Association, the National Institute on Aging, and a pilot grant from the National Institute of Environmental Health Sciences.

This is not the first study to implicate copper in a neurodegenerative disease. In 2011, another group of US researchers reported how copper affected a protein associated with Parkinson's disease.

Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Visit our alzheimer's / dementia section for the latest news on this subject.

Low levels of copper disrupt brain amyloid-ß homeostasis by altering its production and clearance Itender Singh, Abhay Sagare, Mireia Coma and others, PNAS. Published online 19 August 2013 (DOI: 10.1073/pnas.1302212110).

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Paddock, Catharine. "Copper build up in brain 'could explain Alzheimer's dementia'." Medical News Today. MediLexicon, Intl., 20 Aug. 2013. Web.
20 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Copper build up in brain 'could explain Alzheimer's dementia''

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Monday, 19 August 2013

New target inhibiting the progression of Alzheimer's disease

Main Category: Alzheimer's / Dementia
Article Date: 19 Aug 2013 - 0:00 PDT Current ratings for:
New target inhibiting the progression of Alzheimer's disease
not yet ratednot yet rated

To stop the progression of Alzheimer's disease in the early stage, it is necessary to identify new therapeutic targets.

Prof. Yunpeng Cao and team from the First Affiliated Hospital of China Medical University examined striatal-enriched phosphatase 61 expression in the brain tissues of Alzheimer's disease rats using in vivo and in vitro models, and analyzed the molecular mechanism by which striatal-enriched phosphatase 61 regulates N-methyl-D- aspartate receptor 2B transport.

The researchers found that valeric acid (AP5), an N-methyl-D-aspartate receptor antagonist, significantly inhibited amyloid- beta 1-induced increased activity of striatal-enriched phosphatase 61. In addition, the phos-phorylation of N-methyl-D-aspartate receptor 2B at Tyr1472 was impaired in amyloid-beta 1-treated cortical neurons, but knockdown of striatal-enriched phosphatase 61 enhanced the phosphorylation of N-methyl-D-aspartate receptor 2B.

Collectively, these findings, published in Neural Regeneration Research (Vol. 8, No. 21, 2013), indicate that striatal-enriched phosphatase 61 can disturb N-methyl-D-aspartate receptor transport and inhibit the progression of learning and study disturbances induced by Alzheimer's disease. Thus, striatal-enriched phosphatase 61 may represent a new target for inhibiting the progression of Alzheimer's disease.

Article: " What is the new target inhibiting the progression of Alzheimer's disease?," by Lin Zhang1, Jing Yang2, Yunpeng Cao1 (1 Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China; 2 Provincial Key Laboratory of Cardiovascular and Cerebrovascular Drug Basic Research, Liaoning Medical University, Jinzhou 121001, Liaoning Province, China). Neural Regen Res. 2013;8(21):1938-1947. doi:10.3969/j.issn.1673-5374.2013.21.002

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our alzheimer's / dementia section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Research, Neural Regeneration. "New target inhibiting the progression of Alzheimer's disease." Medical News Today. MediLexicon, Intl., 19 Aug. 2013. Web.
19 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'New target inhibiting the progression of Alzheimer's disease'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Thursday, 1 August 2013

Alzheimer's disease linked to poor dental health

Featured Article
Main Category: Alzheimer's / Dementia
Also Included In: Dentistry
Article Date: 31 Jul 2013 - 5:00 PDT Current ratings for:
Alzheimer's disease linked to poor dental health
2 and a half stars1 star

A study has found that people with poor oral hygiene or gum disease could be at higher risk of developing Alzheimer's compared with those who have healthy teeth.

Researchers from the University of Central Lancashire (UCLan) in the UK, discovered the presence of a bacterium called Porphyromonas gingivalis in the brains of patients who had dementia when they were alive. The bug is usually associated with chronic periodontal (gum) disease.

For the study, published in the Journal of Alzheimer's Disease, 10 brain samples from patients with dementia were donated for analysis by a scheme called Brains for Dementia Research, alongside 10 brain samples from people who had not had the disease.

Examination of the samples revealed the presence of the Porphyromonas gingivalis in the samples of the brains affected by Alzheimer's.

This bacteria is usually found in oral cavities, and enters the blood stream through a variety of daily activities, such as chewing, eating and brushing teeth. However, it is more likely to enter the blood stream after invasive dental treatment, where it is possible that the bacteria can enter the brain regularly, the researchers say.

Each time the bacteria enter the brain, the researchers note, this could potentially trigger immune system responses, causing the release of excess chemicals that can kill neurons.

The researchers say that this activity could lead to symptoms such as confusion and deteriorating memory - typical symptoms of Alzheimer's disease.

The study adds to previous findings that Alzheimer's is linked to poor oral health. Research from New York University in 2010 revealed long-term evidence that linked gum inflammation and Alzheimer's disease, finding that gum disease could increase the risk of cognitive dysfunction.

Another study has suggested that other bacteria and viruses are linked to the disease. Research from the University of New Mexico suggested that Herpes simplex virus type 1 (HSV-1) was linked to Alzheimer's. See "Cold sores" connected to cognitive decline.

Professor St John Crean, from the School of Medical Dentistry at UCLAN, says of this most recent research:

"Whereas previous studies have indicated a link between dementia and other bacteria and viruses such as the Herpes simplex virus type 1, this new research indicates a possible association between gum disease and individuals who may be susceptible to developing Alzheimer's disease, if exposed to the appropriate trigger."

"Research currently under way at UCLan is playing an active role in exploring this link," Prof. St John Crean continues, "but it remains to be proven whether poor dental hygiene can lead to dementia in healthy people, which obviously could have significant implications for the population as a whole. It is also likely that these bacteria could make the existing disease condition worse."

The researchers hope that continued donation of brain tissue will enable examination of more samples from people with and without Alzheimer's disease who have relevant dental records.

They add that future research will involve determining whether the Porphyromonas gingivalis could be used as a marker for a blood test that predicts the development of Alzheimer's disease in patients who are at higher risk.

Written by Honor Whiteman


Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Visit our alzheimer's / dementia section for the latest news on this subject. "Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue," Journal of Alzheimer’s Disease, 2013. Abstract/summary Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Whiteman, Honor. "Alzheimer's disease linked to poor dental health." Medical News Today. MediLexicon, Intl., 31 Jul. 2013. Web.
1 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


posted by Jonathan Eisen on 31 Jul 2013 at 8:54 pm

I think this report should be viewed with an enormous dose of skepticism. The study being discussed did not actually make any connections between gum disease and Alzheimer's. They did not even make a specific connection between this kind of bacterium and Alzheimer's. I think it was misleading of the researchers to make any attempt to connect gum diseases and Alzheimer's from their work. I wrote more about this on my blog here: phylogenomics.blogspot.com/2013/07/misleading-microbial-headline-of-month.html.

| post followup | alert a moderator |


posted by Steve on 31 Jul 2013 at 7:38 am

If this study was based on an autopsy at death of those who died from Alzheimer's disease, then I question the researchers to see if they overcame the possibility that it is very difficult to complete oral cares with someone who has Alzheimer's, this is oftened a neglected area in their care..So which came first the poor oral cares or the Alzheimers???

| post followup | alert a moderator |


'Alzheimer's disease linked to poor dental health'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Poor dental health may lead to Alzheimer's, study suggests

Main Category: Dentistry
Also Included In: Alzheimer's / Dementia
Article Date: 31 Jul 2013 - 1:00 PDT Current ratings for:
Poor dental health may lead to Alzheimer's, study suggests
not yet ratednot yet rated

People with poor oral hygiene or gum disease may be at a greater risk of developing Alzheimer's disease, a new study led by The University of Central Lancashire (UCLan) School of Medicine and Dentistry suggests.

The research, which has received international collaboration, and led by Professor Stjohn Crean and Dr Sim Singhrao from UCLan, examined brain samples donated by ten patients without dementia and ten patients suffering from dementia. The research demonstrated the presence of products from Porphyromonas gingivalis in brains from patients suffering from dementia. This bacterium is commonly associated with chronic periodontal (gum) disease. These bacteria enter the bloodstream through daily activities such as eating, chewing, tooth brushing but especially following invasive dental treatment, and from there, potentially enter the brain on a regular basis. The researchers propose that every time they reach the brain, the bacteria may trigger immune system responses by already primed brains cells, causing them to release more chemicals that kill neurons. This could be one mechanism that leads to changes in the brain, which is typical of Alzheimer's disease, and could be responsible for causing symptoms such as confusion and deteriorating memory.

The research benefited from donated brain samples, provided by Brains for Dementia Research, a brain donation scheme supported by Alzheimer's Research UK and Alzheimer's Society. Finding P. gingivalis in the brains from dementia sufferers compared to those without dementia is significant as its presence in Alzheimer's diseased brains has not been documented previously and at the same time adds to a growing body of evidence that suggests an association between poor oral health and dementia.

These published research findings from human brain specimens are further supported by recent (as yet unpublished) research from the same group, on periodontal disease, using animal models, which has been carried out in collaboration with the University of Florida. This animal work has confirmed that P. gingivalis in the mouth finds its way to the brain once the periodontal disease becomes established.

Professor Stjohn Crean, Dean of School of Medicine & Dentistry said:

"Whereas previous studies have indicated a link between dementia and other bacteria and viruses such as the Herpes simplex virus type I, this new research indicates a possible association between gum disease and individuals who may be susceptible to developing Alzheimer's disease, if exposed to the appropriate trigger! Research currently underway at UCLan is playing an active role in exploring this link, but it remains to be proven whether poor dental hygiene can lead to dementia in healthy people, which obviously could have significant implications for the population as a whole. It is also likely that these bacteria could make the existing disease condition worse."

Dr. Sim K. Singhrao, Senior Research Fellow at UCLan said: "We are working on the theory that when the brain is repeatedly exposed to bacteria and/or their debris from our gums, subsequent immune responses may lead to nerve cell death and possibly memory loss. Thus, continued visits to dental hygiene professionals throughout one's life may be more important than currently envisaged with inferences for health outside of the mouth only. To help us prove our hypothesis we are hoping to use the Brains for Dementia Research tissue resource to examine brain tissue from people with both intact and compromised memory who have relevant dental records. The future of the research aims to discover if P. gingivalis can be used as a marker, via a simple blood test, to predict the development of Alzhiemer's disease in at risk patients".

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our dentistry section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

The University of Central Lancashire. "Poor dental health may lead to Alzheimer's, study suggests." Medical News Today. MediLexicon, Intl., 31 Jul. 2013. Web.
31 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Poor dental health may lead to Alzheimer's, study suggests'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Monday, 29 July 2013

'Promising' blood test discovered for Alzheimer's dementia

Featured Article
Main Category: Alzheimer's / Dementia
Also Included In: Neurology / Neuroscience;  Mental Health;  Psychology / Psychiatry
Article Date: 29 Jul 2013 - 0:00 PDT Current ratings for:
'Promising' blood test discovered for Alzheimer's dementia
not yet ratednot yet rated

Researchers in Germany have identified a new blood test that may in future provide much earlier diagnosis of Alzheimer's disease and other degenerative disorders.

The team, from Saarland University and Siemens Healthcare, describe their test in the open access journal Genome Biology. They found it could be used to discriminate between people with Alzheimer's from healthy people without the dementia.

Alzheimer's disease, the most common form of dementia, can currently only be diagnosed with certainty at autopsy, so there is considerable interest in finding reliable, non-invasive biomarkers for diagnosis in living people.

Andreas Keller focused on microRNAs (miRNAs), working with colleagues from Siemens Healthcare, Saarland University at Homburg, and three other German universities, as well as The Scripps Research Institute, of La Jolla, California. The small non-coding RNA molecules are known to influence the way genes are expressed, and miRNAs can be found circulating in bodily fluids, including blood. ?

The team highlighted and tested a 'signature' panel of 12 miRNAs among 48 people with Alzheimer's and 22 healthy controls and discovered different levels in the people with the dementia.

They then developed the tests in a larger cohort of 202 people, comprising not only people with Alzheimer's disease alongside healthy controls, but also patients with other neurological and neurodegenerative disorders.

Here, the new test not only reliably distinguished people with Alzheimer's from the controls with normal health but was also able to identify other conditions.

Useful biomarkers need to be accurate, sensitive (correctly identifying people with the disease) and specific (correctly filtering out people without the disease).

The new test scored highly on all three measures. It was:

93% accurate95% sensitive92% specific.

However, the authors caution that while their blood test shows obvious promise, it still needs to be validated for clinical use, and may eventually work best when combined with other standard diagnostic tools, such as imaging.

Since people with other brain disorders can sometimes show Alzheimer's-like symptoms, the team also looked for the miRNA signature in other patient groups. Interestingly, while the 12 miRNAs were chosen for their potential to separate Alzheimer's disease from controls, the same signature was more than 95% accurate in distinguishing controls from people with various psychiatric disorders, such as schizophrenia, depression and bipolar conditions.

It was less accurate (around 82%) in distinguishing patients with other neurodegenerative disorders, such as mild cognitive impairment, Parkinson's disease and multiple sclerosis, from controls.

The test was also able to discriminate between Alzheimer's patients and those with other neurodegenerative disorders, with an accuracy of around 75%.

The authors believe accuracy in distinguishing Alzheimer's disease from the wider range of neurodegenerative conditions might be improved by tweaking the miRNAs used in the test. They explained:

"Since the 12-miRNA signature has been tailored to differentiate between Alzheimer's disease and controls, other miRNAs may likely contribute to a signature that permits also a better differentiation between the other tested diseases and Alzheimer's disease."

The work at Saarland builds on previous studies highlighting the potential of miRNAs as blood-based biomarkers for many diseases, including numerous cancers. It also suggests that miRNAs could yield useful biomarkers for various brain disorders and sheds further light on the mechanisms underpinning Alzheimer's disease.

Two of the miRNAs are known to be involved in amyloid precursor protein processing, which itself is involved in the formation of plaques, a classic hallmark of Alzheimer's disease. Further, many of the miRNAs are believed to influence the growth and shape of neurons in the developing brain. ?

Written by Nick Valentine


Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Visit our alzheimer's / dementia section for the latest news on this subject. Genome Biology 2013, 14: R78. DOI: 10.1186/gb-2013-14-7-r78. Published online 29 July 2013. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Valentine, Nick. "'Promising' blood test discovered for Alzheimer's dementia." Medical News Today. MediLexicon, Intl., 29 Jul. 2013. Web.
29 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


''Promising' blood test discovered for Alzheimer's dementia'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Friday, 26 July 2013

People who carry a particular gene allele APOE4 can be over 10 times more likely to develop late-onset Alzheimer's disease

Main Category: Alzheimer's / Dementia
Also Included In: Neurology / Neuroscience
Article Date: 24 Jul 2013 - 10:00 PDT Current ratings for:
People who carry a particular gene allele APOE4 can be over 10 times more likely to develop late-onset Alzheimer's disease
not yet rated4 stars

The molecular pathway linking a genetic variant to the common, non-familial form of Alzheimer's disease is revealed in Nature this week. The study boosts our knowledge of the pathology of this neurodegenerative disease, and hints at new directions for therapy.

People who carry a particular gene allele APOE4 can be over 10 times more likely to develop late-onset Alzheimer's disease (LOAD). Asa Abeliovich and colleagues now show that the pattern of gene expression in the brains of APOE4 carriers has similarities to the patterns of gene expression in LOAD patients, and suggest that this altered profile might be an early hallmark of the disease. They identify a handful of genes thought to regulate this unusual transcription profile, including novel and previously known regulators of the amyloid precursor protein (APP), a molecule that has long been implicated in Alzheimer's disease. Genetic variants found at two of the genes may even affect the age when LOAD may set in.

Finally, the team tested a possible therapy, the drug levetiracetam, which inhibits one of the genes identified, and is currently used clinically to treat seizures. The drug suppresses APP processing in cells cultured from APOE4 carriers, making it a molecule worthy of further study.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our alzheimer's / dementia section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Nature. "People who carry a particular gene allele APOE4 can be over 10 times more likely to develop late-onset Alzheimer's disease." Medical News Today. MediLexicon, Intl., 24 Jul. 2013. Web.
26 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'People who carry a particular gene allele APOE4 can be over 10 times more likely to develop late-onset Alzheimer's disease'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here